You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 170 No. 9, May 10, 2010 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Editorial
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Medical Practice
 •Medical Practice, Other
 •Quality of Care
 •Quality of Care, Other
 •Less Is More
 •Comparative Effectiveness
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

LESS IS MORE
Less Is More

How Less Health Care Can Result in Better Health

Deborah Grady, MD, MPH; Rita F. Redberg, MD, MSc,  Editor

Arch Intern Med. 2010;170(9):749-750.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

If some medical care is good, more care is better. Right? Unfortunately, this is often not the case. Across the United States, the rate of use of common medical services varies markedly, but measures of health are not better in areas where more services are provided.1 In fact, the opposite is true—some measures of health are worse in areas where people receive more health services.2

How can more health care lead to worse health outcomes? Almost all tests, imaging procedures, drugs, surgery, and preventive interventions have some risk of adverse effects. In some cases, these harms have been proven to outweigh benefits—for example, treating asymptomatic women with postmenopausal hormone therapy.3 In other cases, services become widely used with inadequate proof of benefit. For example, arthroscopic debridement of the knee for treatment of osteoarthritis was performed about 650 000 times per year . . . [Full Text of this Article]


AUTHOR INFORMATION
Author Affiliations: Department of Medicine (Dr Grady) and School of Medicine (Dr Redberg), University of California, San Francisco, and General Internal Medicine Section, San Francisco Veterans Affairs Medical Center (Dr Grady), San Francisco.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Failing the Acid Test: Benefits of Proton Pump Inhibitors May Not Justify the Risks for Many Users
Mitchell H. Katz
Arch Intern Med. 2010;170(9):747-748.
EXTRACT | FULL TEXT  

High-Dose vs Non–High-Dose Proton Pump Inhibitors After Endoscopic Treatment in Patients With Bleeding Peptic Ulcer: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Chih-Hung Wang, Matthew Huei-Ming Ma, Hao-Chang Chou, Zui-Shen Yen, Chih-Wei Yang, Cheng-Chung Fang, and Shyr-Chyr Chen
Arch Intern Med. 2010;170(9):751-758.
ABSTRACT | FULL TEXT  

Proton Pump Inhibitor Use, Hip Fracture, and Change in Bone Mineral Density in Postmenopausal Women: Results From the Women's Health Initiative
Shelly L. Gray, Andrea Z. LaCroix, Joseph Larson, John Robbins, Jane A. Cauley, JoAnn E. Manson, and Zhao Chen
Arch Intern Med. 2010;170(9):765-771.
ABSTRACT | FULL TEXT  

Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection
Amy Linsky, Kalpana Gupta, Elizabeth V. Lawler, Jennifer R. Fonda, and John A. Hermos
Arch Intern Med. 2010;170(9):772-778.
ABSTRACT | FULL TEXT  

Proton Pump Inhibitors for Prophylaxis of Nosocomial Upper Gastrointestinal Tract Bleeding: Effect of Standardized Guidelines on Prescribing Practice
Patrick S. Yachimski, Elizabeth A. Farrell, Daniel P. Hunt, and Andrea E. Reid
Arch Intern Med. 2010;170(9):779-783.
ABSTRACT | FULL TEXT  

Iatrogenic Gastric Acid Suppression and the Risk of Nosocomial Clostridium difficile Infection
Michael D. Howell, Victor Novack, Philip Grgurich, Diane Soulliard, Lena Novack, Michael Pencina, and Daniel Talmor
Arch Intern Med. 2010;170(9):784-790.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Safely Doing Less: A Missing Component of the Patient Safety Dialogue
Schroeder et al.
Pediatrics 2011;128:e1596-e1597.
FULL TEXT  

The Archives of Internal Medicine: Making a Difference in 2010 and Beyond
Redberg
Arch Intern Med 2011;171:1228-1229.
FULL TEXT  

Understanding provision of chemotherapy to patients with end stage cancer: qualitative interview study
Buiting et al.
BMJ Support Palliat Care 2011;1:33-41.
ABSTRACT | FULL TEXT  

Understanding provision of chemotherapy to patients with end stage cancer: qualitative interview study
Buiting et al.
BMJ 2011;342:d1933-d1933.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2010 American Medical Association. All Rights Reserved.